Keywords: Ironwood Pharma, Forest Labs, Linaclotide, GlaxoSmithKline, XenoPort, Horizant ER, IBS, PNH, neuralgia

FDA filings for Ironwood and Forest for linaclotide, and GSK and XenoPort for Horizant ER

Article | 10 August 2011

Print This

US drugmakers Ironwood Pharmaceuticals (Nasdaq: IRWD) and Forest Laboratories (NYSE: FRX) have submitted a New Drug Application to the US ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in